• geode capital management llc acquires 20,230 shares of xilio therapeutics, inc. (nasdaq:xlo) Defense World Sat, 03 May 2025 07:56:22 GMT
• Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Fri, 02 May 2025 20:32:10 GMT
• Xilio Therapeutics Awards 5,000 Share Stock Option Grant at $0.755 Per Share to New Employee Stock Titan Fri, 02 May 2025 20:30:00 GMT
• Xilio Therapeutics to Present Updated Phase 2 Data for Vilastobart, a Tumor-Activated, Fc-Enhanced Anti-CTLA-4, in Combination wit... The Manila Times Wed, 23 Apr 2025 20:46:09 GMT
• Phase 2 Trial Results: Novel Tumor-Activated Therapy Shows Promise in Hard-to-Treat Colorectal Cancer Stock Titan Wed, 23 Apr 2025 20:30:00 GMT
• xlo - xilio therapeutics, inc. latest stock news & market updates Stock Titan Wed, 23 Apr 2025 20:30:00 GMT
• Xilio Therapeutics Announces Presentation of Phase 2 Data for Vilastobart and Atezolizumab at 2025 ASCO Annual Meeting Nasdaq Wed, 23 Apr 2025 07:00:00 GMT
• 50,086 shares in xilio therapeutics, inc. (nasdaq:xlo) bought by raymond james financial inc. Defense World Mon, 14 Apr 2025 07:00:00 GMT
• Xilio Therapeutics faces Nasdaq delisting over share price By Investing.com Investing.com India Wed, 09 Apr 2025 07:00:00 GMT
• xilio therapeutics faces nasdaq delisting over share price Investing.com Tue, 08 Apr 2025 07:00:00 GMT
• xilio therapeutics announces inducement grants under nasdaq listing rule 5635(c)(4) The Manila Times Sat, 05 Apr 2025 07:00:00 GMT
• Xilio Expands Immuno-Oncology Team: 23K Shares Granted to New Biotech Talent Stock Titan Fri, 04 Apr 2025 07:00:00 GMT
• xilio therapeutics announces inducement grants under nasdaq listing rule 5635(c)(4) GlobeNewswire Fri, 04 Apr 2025 07:00:00 GMT
• xilio therapeutics, inc. (nasdaq:xlo) short interest down 17.1% in march Defense World Wed, 02 Apr 2025 07:00:00 GMT
• xilio therapeutics: strategic pivot and promising pipeline drive buy rating TipRanks Fri, 14 Mar 2025 01:53:06 GMT
• xilio therapeutics, inc. (nasdaq:xlo) short interest update Defense World Thu, 13 Mar 2025 07:49:18 GMT
• xilio therapeutics: strategic pivot and promising pipeline drive buy rating TipRanks Thu, 13 Mar 2025 07:00:00 GMT
• Promising Clinical Developments and Strong Financial Outlook Justify Buy Rating for Xilio Therapeutics TipRanks Wed, 12 Mar 2025 11:36:26 GMT
• xilio therapeutics reports 2024 financial results and pipeline progress TipRanks Wed, 12 Mar 2025 04:19:44 GMT
• xilio advances cancer treatments, secures abbvie collaboration by investing.com Investing.com Australia Wed, 12 Mar 2025 01:41:55 GMT
• xilio therapeutics may offer, sell shares of common stock of up to $50 million from time to time Marketscreener.com Tue, 11 Mar 2025 14:27:30 GMT
• Xilio Therapeutics, Inc. (XLO) Reports Q4 Loss, Lags Revenue Estimates Yahoo Finance Tue, 11 Mar 2025 07:00:00 GMT
• Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2024 Financial Results GlobeNewswire Tue, 11 Mar 2025 07:00:00 GMT
• Xilio Lands Massive $2.1B AbbVie Partnership as Phase 2 Cancer Drug Shows Promise Stock Titan Tue, 11 Mar 2025 07:00:00 GMT
• Xilio Therapeutics inks $50M sales agreement with Leerink Partners Investing.com Tue, 11 Mar 2025 07:00:00 GMT
• Xilio advances cancer treatments, secures AbbVie collaboration Investing.com Tue, 11 Mar 2025 07:00:00 GMT
• xilio therapeutics reports 2024 financial results and pipeline progress TipRanks Tue, 11 Mar 2025 07:00:00 GMT
• xilio therapeutics provides pipeline progress update and anticipates additional vilastobart data in mid-2025 Nasdaq Tue, 11 Mar 2025 07:00:00 GMT
• insider sale alert: xilio therapeutics inc [xlo] – is it time to sell? Knox Daily Tue, 04 Mar 2025 23:17:58 GMT
• xilio therapeutics, inc. (nasdaq:xlo) sees large growth in short interest Defense World Fri, 28 Feb 2025 07:57:46 GMT
• Xilio Therapeutics to Present at TD Cowen 45th Annual Health Care Conference GlobeNewswire Mon, 24 Feb 2025 08:00:00 GMT
• can xilio's novel immunotherapy platform transform cancer treatment? ceo reveals latest progress StockTitan Mon, 24 Feb 2025 08:00:00 GMT
• xilio therapeutics (nasdaq:xlo) stock price down 12.3% – here’s what happened Defense World Sat, 22 Feb 2025 08:22:14 GMT
• xilio (xlo) stock zooms 125% higher on cancer fighting deal with abbvie MSN Thu, 20 Feb 2025 10:22:14 GMT
• xilio therapeutics’ $2.1 billion collaboration with abbvie Global Legal Chronicle Wed, 19 Feb 2025 08:00:00 GMT
• abbvie inc. reports 9.0 % passive stake in xilio therapeutics, inc. as of feb 11 - sec filing Marketscreener.com Tue, 18 Feb 2025 22:41:51 GMT
• stock summary: xilio therapeutics ended the week with a surge of 70.12% Business Upturn Sat, 15 Feb 2025 00:58:00 GMT
• latham advises abbvie on collaboration and option agreement with xilio therapeutics and related equity investment Latham & Watkins LLP Sat, 15 Feb 2025 00:45:19 GMT
• xilio (xlo) stock zooms 125% higher on cancer fighting deal with abbvie MSN Fri, 14 Feb 2025 14:11:29 GMT
• pharma stock roundup: nvs, abbv m&a deals, fda nod to rhhby, pfe drugs Yahoo Finance Fri, 14 Feb 2025 13:03:00 GMT
• Latham Advises AbbVie on Collaboration and Option Agreement With Xilio Therapeutics and Related Equity Investment Latham & Watkins LLP Fri, 14 Feb 2025 08:00:00 GMT
• AbbVie and Xilio announce immunotherapy partnership worth over $2.1bn PMLiVE Fri, 14 Feb 2025 08:00:00 GMT
• abbvie and xilio therapeutics announce collaboration and option agreement MSN Thu, 13 Feb 2025 12:30:37 GMT
• abbvie, xilio partner to develop tumour-activated immunotherapies World Pharmaceutical Frontiers Thu, 13 Feb 2025 10:30:48 GMT
• Client Xilio Therapeutics Enters Collaboration with AbbVie to Develop Novel T Cell Therapies Worth Up to $2.1 Billion Ropes & Gray LLP Thu, 13 Feb 2025 08:00:00 GMT
• AbbVie and Xilio to collaborate on antibody-based immunotherapies Pharmaceutical Technology Thu, 13 Feb 2025 08:00:00 GMT
• We're Hopeful That Xilio Therapeutics (NASDAQ:XLO) Will Use Its Cash Wisely simplywall.st Thu, 13 Feb 2025 08:00:00 GMT
• Cell therapy weekly: preclinical programs for tumor-activated immunotherapies RegMedNet Thu, 13 Feb 2025 08:00:00 GMT
• Xilio advances masked T-cell engagers targeting PSMA, CLDN18.2 and STEAP1 BioWorld MedTech Thu, 13 Feb 2025 08:00:00 GMT
• Petri Dish: a new AbbVie deal, layoffs, and CFO departures The Business Journals Thu, 13 Feb 2025 08:00:00 GMT
• AbbVie Deal Unmasks Promise Of Xilio’s T-Cell Engagers insights.citeline.com Thu, 13 Feb 2025 08:00:00 GMT
• abbvie partners with xilio to develop tumour-activated immunotherapies World Pharmaceutical Frontiers Thu, 13 Feb 2025 08:00:00 GMT
• xilio therapeutics: innovative tce platform and strategic abbvie partnership justify buy rating TipRanks Thu, 13 Feb 2025 08:00:00 GMT
• xilio gains 125% on new deal with abbvie to target prostate and other cancers PUNE.NEWS Thu, 13 Feb 2025 08:00:00 GMT
• xilio gains 125% on new deal with abbvie to target prostate and other cancers PUNE.NEWS Wed, 12 Feb 2025 18:38:57 GMT
• Xilio soars after tie-up with AbbVie to develop cancer treatments TradingView Wed, 12 Feb 2025 15:52:44 GMT
• stock market today: spire global plunged by 48.97% while xilio therapeutics surged by 102.16% in early trading Business Upturn Wed, 12 Feb 2025 15:20:28 GMT
• abbvie and xilio therapeutics, inc. announce collaboration and option agreement to develop novel tumor-activated immunotherapies MarketScreener Wed, 12 Feb 2025 13:41:31 GMT
• xlo - xilio therapeutics, inc. latest stock news & market updates StockTitan Wed, 12 Feb 2025 13:35:54 GMT
• AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies PR Newswire Wed, 12 Feb 2025 08:00:00 GMT
• Xilio Therapeutics Announces Multiple Masked T Cell Engager Programs GlobeNewswire Wed, 12 Feb 2025 08:00:00 GMT
• Major Cancer Breakthrough: AbbVie Invests $52M in Xilio's Revolutionary Tumor-Fighting Technology Stock Titan Wed, 12 Feb 2025 08:00:00 GMT
• Major Biotech Partnership: Xilio Secures $52M AbbVie Deal with Massive $2.1B Milestone Potential Stock Titan Wed, 12 Feb 2025 08:00:00 GMT
• Why Is Nano-Cap Cancer-Focused Xilio Therapeutics Stock Trading Over 100% On Wednesday? Yahoo Finance Wed, 12 Feb 2025 08:00:00 GMT
• Xilio Therapeutics Partners with AbbVie for Immunotherapy Expansion TipRanks Wed, 12 Feb 2025 08:00:00 GMT
• AbbVie Triples Down on T Cell Therapies in Xilio Deal Worth Up to $2.1B BioSpace Wed, 12 Feb 2025 08:00:00 GMT
• AbbVie signs heavily backloaded $2.1B Xilio biobucks pact in Big Pharma's latest T-cell engager deal Fierce Biotech Wed, 12 Feb 2025 08:00:00 GMT
• AbbVie, Xilio strike over $2.1B deal for tumour-activated immunotherapies FirstWord Pharma Wed, 12 Feb 2025 08:00:00 GMT
• AbbVie and Xilio partner for tumor-activated therapies Investing.com Wed, 12 Feb 2025 08:00:00 GMT
• Xilio Therapeutics Shares Surge Premarket on AbbVie Deal marketscreener.com Wed, 12 Feb 2025 08:00:00 GMT
• Xilio (XLO) Stock Zooms 125% Higher On Cancer Fighting Deal with AbbVie TipRanks Wed, 12 Feb 2025 08:00:00 GMT
• AbbVie inks another billion-dollar oncology deal Crain's Chicago Business Wed, 12 Feb 2025 08:00:00 GMT
• abbvie, xilio therapeutics set collaboration, option-to-license agreement Morningstar Wed, 12 Feb 2025 08:00:00 GMT
• xilio shares soar on abbvie collaboration deal by investing.com Investing.com UK Wed, 12 Feb 2025 08:00:00 GMT
• xilio therapeutics announces collaboration with abbvie to advance novel tumor-activated immunotherapies with $52 million upfront p... Nasdaq Wed, 12 Feb 2025 08:00:00 GMT
• xilio therapeutics shares surge premarket on abbvie deal -february 12, 2025 at 08:42 am est Marketscreener.com Tue, 11 Feb 2025 20:52:02 GMT
• abbvie, xilio collaborate on tumor-activated immunotherapies -february 12, 2025 at 08:19 am est Marketscreener.com Tue, 11 Feb 2025 20:52:02 GMT
• xilio therapeutics partners with abbvie for immunotherapy expansion TipRanks Mon, 10 Feb 2025 08:00:00 GMT
• allarity therapeutics (nasdaq:allr) and xilio therapeutics (nasdaq:xlo) financial contrast Defense World Sat, 08 Feb 2025 08:00:00 GMT
• xilio therapeutics announces inducement grants under nasdaq listing rule 5635(c)(4) The Manila Times Tue, 04 Feb 2025 08:00:00 GMT
• Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Mon, 03 Feb 2025 08:00:00 GMT
• xilio's latest executive compensation move: strategic options worth $58,797 granted to key new hires StockTitan Mon, 03 Feb 2025 08:00:00 GMT
• xilio therapeutics, inc. (nasdaq:xlo) short interest down 44.5% in january Defense World Fri, 31 Jan 2025 07:44:07 GMT
• xilio therapeutics, inc. (nasdaq:xlo) sees large increase in short interest Defense World Thu, 30 Jan 2025 08:00:00 GMT
• Xilio stock dives on early colorectal cancer data for masked anti-CTLA-4 FirstWord Pharma Wed, 22 Jan 2025 08:00:00 GMT
• Xilio reports handful of responses for combo in colorectal cancer Endpoints News Wed, 22 Jan 2025 08:00:00 GMT
• Vilastobart set apart? Xilio phase II combo performs in CRC BioWorld MedTech Wed, 22 Jan 2025 08:00:00 GMT
• oncology's best minds set to meet at upcoming 2025 asco gastrointestinal cancers symposium The Globe and Mail Wed, 22 Jan 2025 08:00:00 GMT
• 12 health care stocks moving in wednesday's pre-market session Benzinga Wed, 22 Jan 2025 08:00:00 GMT
• xilio therapeutics announces initial phase 2 data for vilastobart (xtx101), a tumor-activated anti-ctla-4, in combination with ate... The Manila Times Wed, 22 Jan 2025 08:00:00 GMT
• xilio reports results from ongoing phase 2 clinical trial of vilastobart TipRanks Tue, 21 Jan 2025 22:30:59 GMT
• Xilio Therapeutics Announces Initial Phase 2 Data for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Ate... GlobeNewswire Tue, 21 Jan 2025 08:00:00 GMT
• xilio's cancer drug shows 27% response rate in colorectal cancer trial, meets safety goals Stock Titan Tue, 21 Jan 2025 08:00:00 GMT
• xilio therapeutics reports 27% preliminary response rate in phase 2 trial of vilastobart and atezolizumab for mss colorectal cance... Nasdaq Tue, 21 Jan 2025 08:00:00 GMT
• xilio therapeutics announces inducement grant under nasdaq listing rule 5635(4) Marketscreener.com Mon, 20 Jan 2025 15:28:06 GMT
• xilio therapeutics announces inducement grant under nasdaq listing rule 5635(c)(4) The Manila Times Sat, 18 Jan 2025 08:00:00 GMT
• xilio therapeutics awards 60,000-share stock option grant to new employee at $0.955 | xlo stock news Stock Titan Fri, 17 Jan 2025 08:00:00 GMT
• xilio therapeutics announces inducement grant under nasdaq listing rule 5635(c)(4) GlobeNewswire Fri, 17 Jan 2025 08:00:00 GMT
• geode capital management llc grows position in xilio therapeutics, inc. (nasdaq:xlo) Defense World Tue, 14 Jan 2025 08:00:00 GMT
• short interest in xilio therapeutics, inc. (nasdaq:xlo) rises by 221.7% Defense World Tue, 14 Jan 2025 08:00:00 GMT
• xilio therapeutics announces inducement grant under nasdaq listing rule 5635(c)(4) The Manila Times Sat, 11 Jan 2025 08:00:00 GMT
• xilio therapeutics inc [xlo] stock for 6,841 usd was sold by frankenfield christopher james Knox Daily Fri, 10 Jan 2025 12:44:23 GMT
• xilio therapeutics announces inducement grant under nasdaq listing rule 5635(c)(4) GlobeNewswire Fri, 10 Jan 2025 08:00:00 GMT
• xilio therapeutics, inc. (nasdaq:xlo) short interest down 31.9% in december Defense World Sun, 29 Dec 2024 08:00:00 GMT
• xilio therapeutics enters into additional private placement with gilead; issues securities at $25 million aggregate investment Defense World Sat, 21 Dec 2024 08:00:00 GMT
• FDA's principal deputy to depart agency—Chutes & Ladders Fierce Biotech Fri, 20 Dec 2024 08:00:00 GMT
• pharma boom or bust? deciphering xilio therapeutics’ steep stock movements timothysykes.com Fri, 20 Dec 2024 08:00:00 GMT
• gilead sciences acquires $1.83 million in xilio therapeutics stock Investing.com India Fri, 20 Dec 2024 08:00:00 GMT
• Xilio Therapeutics to Present Initial Phase 2 Data for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with At... GlobeNewswire Thu, 19 Dec 2024 08:00:00 GMT
• gilead sciences acquires $1.83 million in xilio therapeutics stock Investing.com Thu, 19 Dec 2024 08:00:00 GMT
• xilio therapeutics reports promising safety data for cancer drug xtx301, secures $25m gilead investment StockTitan Thu, 19 Dec 2024 08:00:00 GMT
• xilio therapeutics, inc. appoints caroline hensley as chief legal officer -december 16, 2024 at 07:30 am est Marketscreener.com Mon, 16 Dec 2024 14:00:15 GMT
• Xilio Therapeutics Appoints Caroline Hensley as Chief Legal Officer GlobeNewswire Mon, 16 Dec 2024 08:00:00 GMT
• xilio therapeutics hires caroline hensley as chief legal officer Bloomberg Law News Mon, 16 Dec 2024 08:00:00 GMT
• xilio therapeutics strengthens leadership team, appoints seres therapeutics veteran as chief legal officer StockTitan Mon, 16 Dec 2024 08:00:00 GMT
• xilio therapeutics, inc. appoints caroline hensley as chief legal officer Marketscreener.com Fri, 13 Dec 2024 20:00:00 GMT
• short interest in xilio therapeutics, inc. (nasdaq:xlo) increases by 317.4% Defense World Thu, 12 Dec 2024 08:00:00 GMT
• after golden cross, xilio therapeutics, inc. (xlo)'s technical outlook is bright MSN Wed, 11 Dec 2024 03:34:08 GMT
• after golden cross, xilio therapeutics, inc. (xlo)'s technical outlook is bright MSN Tue, 10 Dec 2024 11:43:12 GMT
• After Golden Cross, Xilio Therapeutics, Inc. (XLO)'s Technical Outlook is Bright Yahoo Finance Mon, 09 Dec 2024 08:00:00 GMT
• here's why we're not too worried about xilio therapeutics' (nasdaq:xlo) cash burn situation Yahoo Finance Fri, 06 Dec 2024 08:00:00 GMT
• xilio therapeutics issues new employee stock options under nasdaq inducement plan StockTitan Tue, 03 Dec 2024 08:00:00 GMT
Xilio Therapeutics, Inc(NASDAQ:XLO) 
Xilio Therapeutics, Inc., a biotechnology company, designs immunotherapies to improve the immune system for cancer patients. Its checkpoint inhibitor programs include XTX101, is a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1 clinical trials in patients with solid tumors; and cy...
Share this website to your friends